Albany, NY -- (SBWIRE) -- 08/19/2016 -- The neuromodulation devices market is oligopolistic in nature with the top four companies representing nearly 91% of the overall market, finds Transparency Market Research (TMR) in a new study. The key players in the global neuromodulation devices market are Boston Scientific, Cyberonics, Medtronic, and St. Judes Medical.

There are high entry barriers for new players owing to high capital investment and stringent government regulations. "However, large companies can enter the neuromodulation devices market through mergers and by acquiring smaller companies," says the author of the report. The most lucrative way for new vendors to enter the global neuromodulation devices market is through the ownership of groundbreaking and innovative technologies, as technological advancement is a major driving force for the market.

Get Free Report Brochure With Analyst Support: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=627

The neuromodulation devices market is oligopolistic in nature with the top four companies representing nearly 91% of the overall market, finds Transparency Market Research (TMR) in a new study. The key players in the global neuromodulation devices market are Boston Scientific, Cyberonics, Medtronic, and St. Judes Medical.

There are high entry barriers for new players owing to high capital investment and stringent government regulations. "However, large companies can enter the neuromodulation devices market through mergers and by acquiring smaller companies," says the author of the report. The most lucrative way for new vendors to enter the global neuromodulation devices market is through the ownership of groundbreaking and innovative technologies, as technological advancement is a major driving force for the market.

External Funding for Clinical Studies to Augur Well for Sales of Neuromodulation Devices

The rising geriatric population, especially in developed countries such as the U.S., Japan, and Germany are likely to produce notable growth opportunities for the global neuromodulation devices market. This is because of the fact that the aged people are more susceptible to neurological disorders such as Parkinson's and Alzheimer's. Neuromodulation devices have proven to be extremely effective in treating Parkinson's and other chronic illnesses induced by old age.

The growth of the global neuromodulation devices market is backed by external funding to conduct clinical studies. Such initiatives pave the way for the development of technologically updated devices and also reduce the R&D costs pertaining to the development of new products.

Moreover, a rise in the prevalence of chronic diseases common in all age groups, such as migraine and epilepsy has fuelled the demand for neuromodulation devices. "Some of the neurological disorders such as migraine have unmet medical needs, which gives a further push to the growth of the global neuromodulation devices market," says a TMR analyst.

The minimally invasive characteristic of neuromodulation devices has helped the global neuromodulation devices market tread along a promising growth path. The increasing demand for minimally invasive surgeries can be attributed to fast recovery time and scar-less treatment.

Some other factors playing a crucial role in the growth of the global neuromodulation devices market are increasing healthcare related consumer expenditure, add-on therapy nature of neuromodulation devices, and technological advancements that ensure promising treatment options.

Side effects Associated with Neuromodulation Devices to Discourage Adoption Amongst Patients

Neuromodulation devices are planted through a surgery, which can have side effects on the body such as allergy or hoarseness. Neuromodulation devices also carry the risk of damaging the surrounding nerves and blood vessels owing to the electrical impulses generated by them. These factors tend to withdraw the interest of the patients in the neuromodulation devices implantation, thereby impeding the growth of the global neuromodulation devices market. In such a case, the availability of alternate treatment procedures such as drugs and other surgeries (e.g. Pallidotomy) hampers the growth of the global neuromodulation devices market.

The neuromodulation devices have to undergo several rigorous clinical trials prior to their approval and availability in the market. This procedure increases the development cost of neuromodulation devices and challenges the vendors operating in the global neuromodulation devices market, thereby discouraging the growth of the market. Also, the rapidly changing technologies pose a threat to the growth of the market. This trend makes the market volatile and acts as a high impact restraining factor for the market as technologies get outdated and redundant at a great pace.

Browse Full Report @ http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

About Transparency Market Research
Transparency Market Research is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us:
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com